Overall GMDA gets a fundamental rating of 2 out of 10. We evaluated GMDA against 524 industry peers in the Biotechnology industry. GMDA may be in some trouble as it scores bad on both profitability and health. GMDA is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year GMDA has reported negative net income.
In the past year GMDA has reported a negative cash flow from operations.
In the past 5 years GMDA always reported negative net income.
In the past 5 years GMDA always reported negative operating cash flow.

1.2 Ratios

GMDA has a Return On Assets of -61.65%. This is in the lower half of the industry: GMDA underperforms 60.48% of its industry peers.

		Industry Rank	Sector Rank
ROA	-61.65%
ROE	N/A
ROIC	N/A

ROA(3y)-61.87%

ROA(5y)-54.88%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 18.53%, GMDA is doing good in the industry, outperforming 75.47% of the companies in the same industry.
GMDA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	18.53%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

GMDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
GMDA has more shares outstanding than it did 1 year ago.
The debt/assets ratio for GMDA is higher compared to a year ago.

2.2 Solvency

GMDA has an Altman-Z score of -8.53. This is a bad value and indicates that GMDA is not financially healthy and even has some risk of bankruptcy.
GMDA's Altman-Z score of -8.53 is on the low side compared to the rest of the industry. GMDA is outperformed by 74.45% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-8.53

ROIC/WACCN/A

WACC5.78%

2.3 Liquidity

GMDA has a Current Ratio of 2.16. This indicates that GMDA is financially healthy and has no problem in meeting its short term obligations.
GMDA has a worse Current ratio (2.16) than 75.98% of its industry peers.
GMDA has a Quick Ratio of 2.09. This indicates that GMDA is financially healthy and has no problem in meeting its short term obligations.
GMDA's Quick ratio of 2.09 is on the low side compared to the rest of the industry. GMDA is outperformed by 75.47% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.16
Quick Ratio	2.09

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.19% over the past year.

EPS 1Y (TTM)49.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%86.67%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, GMDA will show a very strong growth in Earnings Per Share. The EPS will grow by 50.79% on average per year.
The Revenue is expected to grow by 182.44% on average over the next years. This is a very strong growth

EPS Next Y9.37%

EPS Next 2Y50.84%

EPS Next 3Y51.21%

EPS Next 5Y50.79%

Revenue Next Year808.75%

Revenue Next 2Y935.67%

Revenue Next 3Y499.3%

Revenue Next 5Y182.44%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

GMDA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GMDA. No positive earnings are expected for the next year.